Press release

VTI SPONSORS

 

Visioneering Technologies, Inc., Sponsors “The Truth about Myopia – Part 2”
Clinician Insights from Roundtable Discussion at ARVO 2018

 

Atlanta, GA (October 17, 2018) – To continue to help inform eye care professionals about the growing impact of myopia on their practices, Visioneering Technologies, Inc., has sponsored an educational follow-up supplement, “The Truth About Myopia Part 2” in the September issue of Contact Lens Spectrum

VTI is a global company dedicated to improving vision through a comprehensive product portfolio including the NaturalVue® brand of contact lenses.

Identifying better ways to manage the reported increases in myopia continues to be a growing concern for eye care practitioners. The supplement highlights a roundtable discussion with vision care leaders and practitioners who have built successful programs within their practices. The roundtable was held during the annual meeting for The Association for Research in Vision and Ophthalmology (ARVO).

Faculty leading the roundtable included S. Barry Eiden, OD (moderator) president and medical director of North Suburban Vision Consultants; Thomas Aller, OD, a private practitioner who has been conducting myopia research for 25 years and is the editor of manage myopia.org; Jeffrey Cooper, MS, OD, president and medical director of Cooper Eye Care; Kate Gifford, BAppSc(Optom)Hons, GCOT, PhD, a clinician-scientist and leading peer educator in private practice in Brisbane, Australia; Justin Kwan, OD, assistant professor at Southern California College of Optometry at Marshall B. Ketchum University, chief of Cornea and Contact Lens service. Additional information on presenters and their support are reported in the supplement.

“The first step to improving myopia management is to learn as much as you can to understand why it’s something that needs to be treated differently than it has been treated historically,” said Dr. Aller. “The next step is to become educated about the options for addressing myopia so that you’re able to use them skillfully. Then, it’s a matter of committing to managing myopia in your practice.”

To access the supplement, or for additional insights into myopia management, visit Contact Lens Spectrum.

 

About Visioneering Technologies, Inc.

Visioneering Technologies Inc. (VTI), headquartered in northern Atlanta, Georgia, is an innovative company dedicated to developing products that improve vision. With a portfolio of technologies, the company uses creative and differentiated design approaches to develop products that enhance practitioner and patient experiences. VTI optical designs have been awarded twelve patents worldwide, with an additional seven pending. Strength in science, an entrepreneurial culture, and the ability to bring technology to life make Visioneering Technologies, Inc. a company to watch.  For more information, visit www.vtivision.com or call 844-884-5367.

 

MKT-VTI-PR61 r2

 

Disclaimer:  This information describes uses for multifocal contact lenses that have not been approved or cleared by the FDA for use in the United States.

NATURALVUE® INDICATIONS FOR USE
NaturalVue® (etafilcon A) Multifocal 1 Day Disposable Soft Contact Lenses are indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia), and/or presbyopia, and myopia progression control in normal eyes.